Canopy Growth Corporation

Equities

WEED

CA1380357048

Pharmaceuticals

Delayed Toronto S.E. 13:42:26 2024-06-17 EDT 5-day change 1st Jan Change
9.9 CAD -0.90% Intraday chart for Canopy Growth Corporation -1.10% +46.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Acreage Closes US$10-Million Private Placement of Convertible-Debenture Units MT
Toronto Stocks Edge Higher; Transcontinental Rises on Higher 2Q Adjusted Profit DJ
Canopy Growth Sets up $250 Million At-the-Market Equity Program; Shares Fall MT
Canopy Growth Down 3% In US Premarket As Establishes US$250 Million At-The-Market Program To "Further Enhance the Company's Financial Position And Facilitate Growth" MT
Canopy Growth Brief: Establishing US$250 Million At-The-Market Program To "Further Enhance the Company's Financial Position And Facilitate Growth" MT
Canopy Growth Corporation to Seek Acquisitions CI
Acreage Entering into US$10 Million Private Placement; Comes Amid Transaction With Canopy Growth MT
Acreage Brief: Entering into US$10 Million Private Placement MT
Canopy Growth Exercises Option to Acquire Class E Shares of Acreage MT
Canopy Growth Exercises Option to Acquire Acreage Class E Shares Following on 2019 Acquisition Agreement MT
Canopy Growth Brief: Announcing Exercise of Acreage Options "Paving the Way" for Acquisition by Canopy USA MT
Piper Sandler Reviews Canopy Growth's Q4 MT
Transcript : Canopy Growth Corporation, Q4 2024 Earnings Call, May 30, 2024
Canopy Growth Q4 Loss Narrows as Net Revenue Rises 7% MT
Canopy Growth Brief: Q4 FY 2024 Net Revenue increased 7% year-over-year, or 16% excluding divested businesses MT
Canopy Growth Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Canopy Growth Brief: Q4 Operating loss from continuing operations of $107 Million MT
Canopy Growth Corporation Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Pot stocks rise as US unveils proposal to ease restrictions on marijuana RE
US Government Reclassifies Marijuana to Less-Restrictive Category MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification DJ
Justice Department Set to Post Cannabis Reclassification Plans MT
Investors wary of US cannabis ETFs despite recent rally RE
Canopy USA Exercises Options to Acquire Wana, Jetty MT
Canopy Growth Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty MT
Chart Canopy Growth Corporation
More charts
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
9.99 CAD
Average target price
8.89 CAD
Spread / Average Target
-11.01%
Consensus
  1. Stock Market
  2. Equities
  3. WEED Stock
  4. News Canopy Growth Corporation
  5. Canopy Growth Brief: Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty